A class action lawsuit has been filed against Insulet Corporation and certain officers for allegedly making false and misleading statements about defective manufacturing controls and safety risks of their products between May 2025 and May 2026. The lawsuit claims these issues posed risks of regulatory violations and injury, harming investors who bought Insulet securities during this period. Investors have until August 31, 2026, to join the case or seek lead plaintiff status. The law firm Bronstein, Gewirtz & Grossman is representing affected investors on a contingency basis, aiming to recover damages and hold the company accountable.
Canada's federal government and British Columbia have signed the Cooperative Prosperity Agreement, aiming to unlock over $200 billion in new investments focused on natural resources like LNG, critical minerals, and infrastructure. Concurrently, Alber...
Crédit Agricole has increased its ownership in Banco BPM to 29.3%, surpassing the 25% threshold through market purchases and derivatives. This move reflects Crédit Agricole's commitment as a long-term investor supporting the Italian economy and stren...
BlackRock, Inc. notified Umicore on July 1, 2026, that its direct voting rights in the company fell below the 5% legal threshold on June 30, 2026. After the transaction, BlackRock holds 4.97% direct voting rights and 0.68% equivalent financial instru...
BlackRock, Inc. notified Umicore that its direct voting rights dropped below the 5% threshold on June 30, 2026, holding 4.97% direct voting rights and 0.68% through equivalent financial instruments, totaling 5.65%. This disclosure complies with Belgi...
BlackRock, Inc. has notified Umicore that it crossed below the 5% threshold of direct voting rights on June 30, 2026, holding 4.97% directly. Including equivalent financial instruments, BlackRock's total voting rights amount to 5.65%. This disclosure...
